0 Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy

被引:7
|
作者
Shinohara, Tsuyoshi [1 ]
Yamada, Hiroyuki [1 ]
Fujimori, Yoshiro [1 ]
Yamagishi, Kiyofumi [1 ]
机构
[1] Hokushir Gen Hosp, Dept Surg, Nakaro, Nagano, Japan
来源
关键词
malignant pleural effusion; breast cancer; late recurrence; endocrine therapy;
D O I
10.12659/AJCR.889249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The most common site of postoperative breast cancer recurrence is bone, followed by local relapse, lung, and liver. The majority of relapses occur within the first 3 years after surgery. Pleural recurrences more than 10 years after surgery are rare. Case Report: A 94-year-old woman who had undergone modified radical mastectomy for right breast cancer (invasive ductal carcinoma, pT2, pN1, ER+, PgR+) 12 years earlier presented to our hospital with carcinomatous pleuritis and a chief complaint of dyspnea. Endocrine therapy with oral letrozole was started and the pleural effusion had disappeared 3 months later. Conclusions: Oral endocrine therapy may be effective for the treatment of late recurrence of hormon receptor-positive breast cancer in elderly women.
引用
收藏
页码:184 / 187
页数:4
相关论文
共 50 条
  • [21] Malignant Pleural and Pericardial Effusion in Invasive Breast Cancer: Impact of the Site of the Primary Tumor
    W. Pokieser
    P. Cassik
    G. Fischer
    M. Vesely
    W. Ulrich
    C. Peters-Engl
    Breast Cancer Research and Treatment, 2004, 83 : 139 - 142
  • [22] Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor
    Pokieser, W
    Cassik, P
    Fischer, G
    Vesely, M
    Ulrich, W
    Peters-Engl, C
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (02) : 139 - 142
  • [24] Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion
    dos Santos, Giovana Tavares
    Prolla, Joao Carlos
    Camillo, Natalia Dressler
    Zavalhia, Lisiane Silveira
    Ranzi, Alana Durayski
    Bica, Claudia Giuliano
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2012, 38 (04) : 487 - 493
  • [25] An audit of advanced breast cancer treated solely with endocrine therapy over 5 years period
    Tan, M. L. -H.
    McNamara, K.
    Azam, A.
    Carmichael, A.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 181 - 181
  • [26] Management of resistant lung cancer malignant pleural effusion by intrapleural gene therapy.
    Zarogoulidis, K
    Kontakiotis, T
    Papagiannis, A
    Xafenias, A
    Kortsaris, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 236S - 236S
  • [27] MALIGNANT PLEURAL EFFUSION: UNVEILING AN UNUSUAL COURSE OF PAPILLARY THYROID CARCINOMA AFTER YEARS OF REMISSION
    Burke, Jamie
    Van Hook, Reed
    CHEST, 2024, 166 (04) : 4251A - 4251A
  • [28] Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion
    Cheng, Yi-Jing
    Lin, Ching-Kai
    Chen, Chao-Yu
    Chien, Po-Chien
    Chuan, Ho-Hsien
    Ho, Chao-Chi
    Cheng, Yun-Chien
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] PLEURAL ASPERGILLOSIS 12 YEARS AFTER PULMONARY ASPERGILLOSIS TREATED BY LOBECTOMY
    BARIETY, M
    POULET, J
    ALMOSNI, M
    PRESSE MEDICALE, 1969, 77 (17): : 648 - &
  • [30] Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion
    Yi-Jing Cheng
    Ching-Kai Lin
    Chao-Yu Chen
    Po-Chien Chien
    Ho-Hsien Chuan
    Chao-Chi Ho
    Yun-Chien Cheng
    Scientific Reports, 10